In medicine, we're often led to believe that "more is better." More interventions will result in better outcomes. More monitoring will result in earlier detection. More education will improve ...
In this comprehensive systematic review of randomized controlled trials, which included a total number of 471 patients, torsemide significantly reduced HF and CV-related hospital readmissions compared ...
Thirst outcomes were investigated among patients with stable heart failure (HF), due to the limited data available on this relationship and how it, along with fluid and sodium intake, influences ...
CHICAGO -- The choice between furosemide and torsemide didn't matter for longer-term clinical outcomes of hospitalized heart failure patients, according to the comparative effectiveness trial ...
Lisbon, Portugal – 13 May 2024: Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure ...
Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction ...
Please provide your email address to receive an email when new articles are posted on . Dapagliflozin did not improve diuretic efficiency for patients hospitalized with acute HF. It did, however, ...
Uncertainty regarding diuretic efficacy and optimal dosing in hemodialysis likely contributes to practice variation, according to investigators. A new study finds “substantial” variation in oral ...
Please provide your email address to receive an email when new articles are posted on . Compared with placebo, Wegovy improved HF symptoms and physical limitations in patients with obesity-related ...
LISBON, Portugal—The use of intravenous furosemide plus the thiazide-like diuretic metolazone resulted in significantly better natriuresis, as well as greater increase in urine volume and a larger ...
The most common downstream events included worsening kidney function, orthostasis, electrolyte abnormalities, and falls. HealthDay News — The potential downstream harms in the gabapentinoid ...